Published in N Engl J Med on October 18, 2001
Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev (2011) 4.15
Antimicrobial use in animal feed--time to stop. N Engl J Med (2001) 1.84
In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother (2006) 1.55
What do we feed to food-production animals? A review of animal feed ingredients and their potential impacts on human health. Environ Health Perspect (2007) 1.52
Airborne multidrug-resistant bacteria isolated from a concentrated swine feeding operation. Environ Health Perspect (2005) 1.49
Agricultural antibiotics and human health. PLoS Med (2005) 1.31
Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. J Theor Biol (2007) 1.24
Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother (2003) 1.20
The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria. PLoS One (2008) 1.12
Antimicrobial resistance of Enterococcus species isolated from produce. Appl Environ Microbiol (2004) 1.05
VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. Appl Environ Microbiol (2007) 1.03
Characterization of vancomycin-resistant Enterococcus faecium isolates from broiler poultry and pig farms in England and Wales. J Clin Microbiol (2005) 0.91
Influx of enterococci and associated antibiotic resistance and virulence genes from ready-to-eat food to the human digestive tract. Appl Environ Microbiol (2007) 0.85
Effect of raw-milk cheese consumption on the enterococcal flora of human feces. Appl Environ Microbiol (2003) 0.84
Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States. J Clin Microbiol (2006) 0.80
Meta-analysis of experimental data concerning antimicrobial resistance gene transfer rates during conjugation. Appl Environ Microbiol (2008) 0.78
Resistant bacteria in retail meats and antimicrobial use in animals. N Engl J Med (2002) 0.77
Resistant bacteria in retail meats and antimicrobial use in animals. N Engl J Med (2002) 0.75
Mini-review: Epidemiology and zoonotic potential of multiresistant bacteria and Clostridium difficile in livestock and food. GMS Hyg Infect Control (2014) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2002) 0.75
Curtailing antibiotic use in agriculture: it is time for action: this use contributes to bacterial resistance in humans. West J Med (2002) 0.75
The Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular Basis. Front Microbiol (2016) 0.75
Resistant bacteria in retail meats and antimicrobial use in animals. N Engl J Med (2002) 0.75
Resistant bacteria in retail meats and antimicrobial use in animals. N Engl J Med (2002) 0.75
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63
Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother (1996) 2.62
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill (2010) 2.09
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax (1992) 1.97
Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett (1999) 1.93
Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae. Infect Immun (1983) 1.93
Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2003) 1.91
Crossed immunoelectrophoretic analysis of Legionella pneumophila serogroup 1 antigens. Infect Immun (1983) 1.89
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis (1986) 1.84
Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis (1994) 1.83
Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect (1997) 1.79
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect (1995) 1.63
Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection (1995) 1.61
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect (2007) 1.61
Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 1.59
National hand hygiene campaigns in Europe, 2000-2009. Euro Surveill (2009) 1.58
Are variable repeats in the spa gene suitable targets for epidemiological studies of methicillin-resistant Staphylococcus aureus strains? Eur J Clin Microbiol Infect Dis (1996) 1.54
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun (1990) 1.51
Emergence and characterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol (2008) 1.51
General practitioners on dementia: tasks, practices and obstacles. Patient Educ Couns (2000) 1.49
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.49
Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol (2004) 1.49
In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection (2002) 1.48
Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med (1999) 1.48
Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis (1992) 1.46
Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol (1999) 1.45
[Survey of stress in women. Heart disease in Stockholm women is caused by both family- and work-related stress]. Lakartidningen (1997) 1.44
Coagulase and protein A polymorphisms do not contribute to persistence of nasal colonisation by Staphylococcus aureus. J Med Microbiol (1997) 1.40
Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol (1992) 1.39
Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother (1995) 1.37
Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med (1999) 1.36
Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother (2002) 1.35
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents (2000) 1.33
[Treatment of upper respiratory tract infections]. Ugeskr Laeger (2000) 1.31
Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol (1999) 1.31
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother (2005) 1.28
Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med (1998) 1.28
Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (1989) 1.28
Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods. J Antimicrob Chemother (1999) 1.24
Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med (1986) 1.24
Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J Exp Med (1993) 1.23
Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother (1997) 1.21
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother (1998) 1.19
European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics. Euro Surveill (2014) 1.18
Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun (1991) 1.18
Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill (2009) 1.17
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro Surveill (2007) 1.16
Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med (2004) 1.15
Quantitative immunoelectrophoretic analysis of Salmonella typhi antigens and of corresponding antibodies in human sera. Acta Pathol Microbiol Scand B (1980) 1.15
Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun (2010) 1.14
Isolation of Staphylococcus aureus clumping factor. Infect Immun (1985) 1.14
Clumping of Staphylococcus aureus by human fibronectin. Acta Pathol Microbiol Scand B (1981) 1.14
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother (2003) 1.13
International variations in youth drug use: the effect of individual behaviours, peer and family influences, and geographical location. Eur Addict Res (2000) 1.12
Hospital-acquired infections in a burns unit caused by an imported strain of Staphylococcus aureus with unusual multi-resistance. J Hyg (Lond) (1982) 1.10
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol (1990) 1.08
Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents (2007) 1.08
Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS (1993) 1.08
Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies. Clin Diagn Lab Immunol (1995) 1.08
Role of the Yersinia outer membrane protein YadA in adhesion to rabbit intestinal tissue and rabbit intestinal brush border membrane vesicles. APMIS (1991) 1.07
Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis (2001) 1.07
Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother (2001) 1.07
Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect Immun (1994) 1.07
Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrob Agents Chemother (1997) 1.06
[Daily single-dose aminoglycoside administration. Therapeutic and economic benefits]. Ugeskr Laeger (1993) 1.06
Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob Agents Chemother (1999) 1.06
European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill (2009) 1.05
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemother (2000) 1.05
Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides (1999) 1.04
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA. Clin Exp Immunol (1990) 1.04
Stomatococcus mucilaginosus endocarditis. Eur J Clin Microbiol (1985) 1.04
Interaction between limulus amoebocyte lysate and soluble antigens from Pseudomonas aeruginosa and Staphylococcus aureus studied by quantitative immunoelectrophoresis. J Clin Microbiol (1985) 1.03
Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis (2011) 1.03
Evaluation of methods for the detection of nasal carriage of Staphylococcus aureus. APMIS (1994) 1.02
Bacterial histamine release by immunological and non-immunological lectin-mediated reactions. Allergy (1984) 1.02
Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun (1999) 1.00